Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
AgeUp to 18
SponsorSherief Abd-Elsalam

About this trial

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Eligibility criteria

Qualifiers

Children with traumatic brain injury: Moderate and Severe.

Disqualifiers

Underlying CNS disorders,

Trial design

Treatments tested in this trial

  • Nucleo CMP Forte

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution